H.C. Wainwright & Co., LLC

We are pleased to have served as Placement Agent for SeaStar Medical’s $10 Million Follow-On offering. Learn more about H.C. Wainwright and see all of our transactions online at www.hcwco.com/transactions

Join Bitfarms (NASDAQ: BITF) at our next HCW @ Home Virtual Fireside Chat on July 17, 2024 at 4pm ET. Our research analyst, Mike Colonnese, will be joined by Bitfarms Chief Executive Officer, Ben Gagnon, and Chief Financial Officer, Jeff Lucas, for an insightful discussion that explores the company’s strategic pipeline opportunities and future market prospects. To register, please visit https://ct.to/DiWYQlV

HCW’s 26th Annual Global Investment Conference will be held September 9th– 11th at the Lotte New York Palace. For more information, including accommodations and registration, please visit: https://lnkd.in/dVcQVaUE Please note, registrations are subject to approval. Reach out to your HCW representative with any questions or email our Corporate Access team.

Don’t miss out on the opportunity to engage with experts and discover cutting-edge developments in renal health at our upcoming annual Kidney Conference on Monday, July 15th. Join HCW and our esteemed panelists to gain invaluable insights and networking opportunities.   Institutional investors, click this link to register: https://ct.to/AO7pdJg

Our 3rd Annual Kidney Conference will take place virtually on July 15th. Join us for a day of insightful panel discussions to stay informed on developments in the kidney space, company 1x1 meetings, and hear updates from the following participating companies: Akebia Therapeutics, Aurinia Pharmaceuticals Inc., CalciMedica, Kezar Life Sciences, POXEL, Regulus Therapeutics, Rockwell Medical, Inc., Saghmos Therapeutics, Travere Therapeutics, Unicycive Therapeutics, Vera Therapeutics, Inc., Walden Biosciences, and ZyVersa Therapeutics Inc. For more information and to register, visit: https://lnkd.in/eJeRyQHW

We are pleased to have served as Placement Agent for Checkpoint Therapeutics, Inc. $12 Million Follow-On offering. Learn more about H.C. Wainwright and see all of our transactions online at www.hcwco.com/transactions

We are excited to host the next HCW @ Home Virtual Fireside Chat on July 11, 2024 at 3pm ET with Barinthus Biotherapeutics (NASDAQ: BRNS). Our covering research analyst, Yi Chen, will be joined by Barinthus Chief Executive Officer, Bill Enright, for an insightful discussion into the company’s strategic pipeline prioritization and future market prospects. To register, please visit https://ct.to/hPuWylo